Pioneering new biochip technology has been developed which scientists claim could help fight a range of life-threatening diseases, including cancer.
The PhosphoSense biochip can detect the activity of enzymes called kinases, which regulate a number of important biological processes - and which, when they become over-active or irregular, can cause a number of deadly diseases.
As well as cancer, kinases have been linked to autoimmune disorders, Alzheimer's and diabetes.
By monitoring the activity of the enzymes, the biochip can allow drug companies to measure the effect of a large number of compounds, helping researchers choose which should be developed into medicinal drugs.
The patented technology was developed at the University of Bath by Dr Pedro Estrela, PhD student Nikhil Bhalla, Dr Mirella Di Lorenzo and Dr Giordano Pula, and published in the Scientific Reports journal.
The team is now hoping to work alongside industrial partners to develop a prototype.